D. Lafont et al./Carbohydrate Research 310 (1998) 9±16
13
(dd, 1 H, J4,5 4.4 Hz H-4), 5.02 (m, 1 H, H-5), 4.72
(dd, 1 H, H-2), 3.87 (dd, 1 H, J5,6a 1.5 Hz, J6a,6b
7.8 Hz, H-6a), 3.82 (ddd, 1 H, J5,6b 5.8 Hz, J6b,P
9.0 Hz, H-6b), 2.27 (s, 3 H, CH3Ph), 2.18, 1.99,
1.95 (3s, 9 H, CH3COO); 31P NMR (CDCl3): ꢂ
43.26; 13C NMR (CDCl3): ꢂ 169.08, 169.01, 168.96
(3 C, CH3COO), 144.72 (CSO2), 137.95 (CCH3),
136.13 (d, 3 C, JC,P 2.9 Hz, Cpara), 133.58 (d, 6 C,
JC,P 11.1 Hz, Cortho), 130.38 (d, 6 C, JC,P 13.2 Hz,
Cmeta), 127.93 and 125.98 (4 C, PhSO2), 117.92 (d,
3 C, JC,P 102.0 Hz, Cipso), 86.40 (d, JC1,P 3.3 Hz, C-
1), 74.55 (d, JC5,P 6.3 Hz, C-5), 71.00 (d, JC2,P
7.0 Hz, C-2), 67.03 (C-3), 63.94 (C-4), 48.34 (C-6),
21.05 (PhCH3), 20.54, 20.35, 20.33 (3 C,
CH3COO). Anal. Calcd for C37H38NO10PS, 2H2O
(755.76): C, 58.80; H, 5.60; N, 1.85. Found: C,
58.53; H, 5.38, N, 1.66.
aorded a mixture of the expected product 10 or 11
(from 7 or 8) or 12/13 (from 9) with PPh3O. These
compounds were too instable to be puri®ed by
column chromatography on silica-gel.
NMR spectroscopy of crude 2,3,4-tri-O-acetyl-6-
amino-1,6-anhydro-6-deoxy-b-d-glucopyranose (10).
1H (CD3-COCD3): ꢂ 4.98 (ddd, 1 H, J1,2, J1,3
1.4 Hz, J1,5 0.6 Hz, H-1), 4.78 (dddd, 1 H, J2,3, J3,4,
J3,5 1.4 Hz, H-3), 4.54 (dddd, 1 H, J2,4, J4,5 1.4 Hz,
J4,6b 0.6 Hz, H-4), 4.50 (dddd, 1 H, J5,6a 7.0 Hz,
J5,6b 1.5 Hz, H-5), 3.15 (dd, 1 H, J6a,6b 10.2 Hz, H-
6a), 3.09 (ddd, 1 H, H-6b), 2.08, 2.06, 2.06 (3s, 9 H,
CH3COO); 13C (CD3COCD3): ꢂ 169.19, 169.10,
168.88 (3 C, CH3COO), 88.05 (C-1), 74.03 (C-5),
72.95 (C-4), 72.90 (C-2), 71.07 (C-3), 46.07 (C-6),
20.68, 20.59, 20.19 (3 C, CH3COO).
NMR spectroscopy of crude 2,3,4-tri-O-acetyl-6-
amino-1,6-anhydro-6-deoxy-b-d-galactopyranose
2,3,4-Tri-O-acetyl-1,6-anhydro-6-deoxy-6-triphenyl-
phosphonioamino-b-d-mannopyranose p-tolylsulf-
onate (9).ÐObtained quantitatively as described
above from 2,3,4-tri-O-acetyl-6-O-p-tolylsulfonyl-
ꢀ-d-mannopyranosyl azide (6) (1.00 g, 2.06 mmol).
1
(11). H (CD3-COCD3): ꢂ 5.16 (ddd, 1 H, J1,3, J2,3
1.4 Hz, J3,4 5.5 Hz, H-3), 5.08 (ddd, 1 H, J4,5
4.3 Hz, J4,6b 0.9 Hz, H-4), 4.98 (dd, 1 H, J1,2 1.4 Hz,
H-1), 4.62 (dd, 1 H, H-2), 4.37 (ddd, 1 H, J5,6a
1.0 Hz, J5,6b 6.4 Hz, H-5), 3.39 (dd, 1 H, J6a,6b
9.8 Hz, H-6a), 3.03 (ddd, 1 H, H-6b), 2.15, 2.13,
2.03 (3s, 9 H, CH3COO); 13C (CD3COCD3): ꢂ
170.23, 169.94, 169.79 (3 C, CH3COO), 88.03 (C-1),
73.86 (C-2), 72.77 (C-5), 68.52 (C-3), 66.96 (C-4),
44.78 (C-6), 20.87, 20.78, 20.60 (3 C, CH3COO).
Acetylation of the crude coumpounds 10, 11 or
12/13 with a 2:1 pyridine±Ac2O mixture (15 h) fol-
lowed by concentration aorded products 14, 15 or
16 which were puri®ed by column chromatography
(7:1 EtOAc±EtOH).
ꢀ
1
Amorphous solid; [ꢁ]d 28.2 (c 1.0, CHCl3); H
NMR (CD3COCD3): ꢂ 8.12±7.85 (m, 15 H, 3 Ph),
7.63 and 7.02 (2d, 4 H, J 8.0 Hz, CH3-Ph), 5.78
(ddd, 1 H, J1,2 2.7 Hz, J1,3 0.7 Hz, J1,P 8.7 Hz, H-1),
5.35 (dddd, 1 H, J2,3 5.2 Hz, J3,4, J3,5 1.4 Hz, H-3),
5.09 (dddd, 1 H, J4,5 1.4 Hz, J5,6a 2.7 Hz, J5,6b
7.2 Hz, H-5), 5.03 (dd, 1 H, H-2), 5.01 (m, 1 H, H-
4), 4.05 (ddd, 1 H, J4,6a 1.4 Hz, J6a,6b 9.9 Hz, H-6a),
3.84 (ddd, 1 H, J6b,P 13.2 Hz, H-6b), 2.37 (s, 3 H,
CH3Ph), 2.27, 2.13, 1.70 (3s, 9 H, CH3COO); 31P
NMR (CDCl3): ꢂ 45.69; 13C NMR (CDCl3): ꢂ
169.19, 169.10, 168.88 (3 C, CH3COO), 144.70
(CSO2), 137.83 (CCH3), 135.94 (d, 3 C, JC,P 2.7 Hz,
Cpara), 133.63 (d, 6 C, JC,P 8.9 Hz, Cortho), 130.51
(d, 6 C, JC,P 13.2 Hz, Cmeta), 127.86 and 125.86 (4
C, PhSO2), 118.22 (d, 3 C, JC,P 101.9 Hz, Cipso),
86.64 (C-1), 75.66 (d, JC5,P 5.4 Hz, C-5), 71.09 (C-
4), 66.45 (C-3), 66.14 (d, JC2,P 6.4 Hz, C-2), 49.67
(C-6), 21.92 (PhCH3), 20.68, 20.59, 20.19 (3 C,
CH3COO). Anal. Calcd for C37H38NO10PS, 2H2O
(755.76): C, 58.80; H, 5.60; N, 1.85. Found: C,
58.89; H, 5.36, N, 1.79.
6-Acetamido-2,3,4-tri-O-acetyl-1,6-anhydro-6-
deoxy-b-d-glucopyranose
described above from 7 (0.695 mmol); 0.192 g
(14).ÐObtained
as
ꢀ
(84%): mp 124 C; [ꢁ]d 45.8ꢀ (c 1.0, CHCl3); Rf
1
0.31 (EtOAc); major rotamer (52%): H NMR
(CDCl3): ꢂ 5.74 (bs, 1 H, H-1), 4.93 (bs, 1 H, H-3),
4.88 (bs, 1 H, H-2), 4.72 (m, 1 H, H-5), 4.63 (bs, 1
H, H-4), 3.65 (m, 2 H, H-6a,6b), 2.20, 2.19, 2.17,
2.08 (4s, 12 H, CH3CO); 13C NMR (CDCl3): ꢂ
169.70, 169.15, 168.31, 167.82 (4 C, CH3CO), 84.00
(C-1), 75.65 (C-5), 69.66 (C-4), 68.87 (C-3), 66.36
(C-2), 44.76 (C-6), 22.19, 20.78, 20.68, 20.56 (4 C,
CH3CO); minor rotamer (48%): 1H NMR
(CDCl3): ꢂ 5.51 (bs, 1 H, H-1), 4.91 (bs, 1 H, H-3),
4.69 (m, 1 H, H-5), 4.67 (bs, 1 H, H-4), 4.61 (bs, 1
H, H-2), 3.72 (dd, 1 H, J5,6a 6.6 Hz, J6a,6b 9.2 Hz,
H-6a), 3.59 (d, 1 H, H-6b), 2.17, 2.16, 2.10, 2.08
(4s, 12 H, CH3CO); 13C NMR (CDCl3): ꢂ 169.94,
169.63, 168.76, 166.90 (4 C, CH3CO), 83.88 (C-1),
General procedure for the preparation of the
6-acetamido-2,3,4-tri-O-acetyl-1,6-anhydro-6-deoxy-
b-d-hexopyranoses (14±16).ÐA soln of the crude
salts 7, 8 or 9, prepared from 3, 4 or 6 (0.337 g,
0.695 mmol) and PPh3 (0.191 g, 1.05 equiv in
CH2Cl2 (1 mL), was applied at the top of a column
of Dowex 2X8 (OH ) in CH2Cl2 and eluted with
the same solvent. Concentration of the eluate